Pill imprint GILEAD 10 LOGO has been identified as Hepsera 10 mg.

The Hepsera 10mg medication above is manufactured by Gilead Sciences.

Hepsera 10 MG Online | Buy Adefovir Dipivoxil

Buy Hepsera 10 mg Online | Generic Hepsera 10 mg

Too low to display
  • Review
  • TAG : Viroflex | Hepsera 10mg Tabletten
ADD TO CART
  • In patients with adequate renal function, increases in serum creatinine >/= 0.3 mg/dL from baseline were observed in 4% of patients treated with HEPSERA 10 mg daily compared with 2% of patients in the placebo group by week 48. No patients developed a serum creatinine increase >/= 0.5 mg/dL from baseline by week 48. By week 96, 10% and 2% of HEPSERA-treated patients, by Kaplan-Meier estimate, had increases in serum creatinine >/= 0.3 mg/dL and >/= 0.5 mg/dL from baseline, respectively (no placebo-controlled results were available for comparison beyond week 48). Of the 29 of 492 patients with elevations in serum creatinine >/= 0.3 mg/dL from baseline, 20 out of 29 resolved on continued treatment ((See Special Risk Patients section below for changes in serum creatinine in patients with underlying renal insufficiency at baseline).

    In patients with adequate renal function, increases in serum creatinine >/= 0.3 mg/dL from baseline were observed in 4% of patients treated with HEPSERA 10 mg daily compared with 2% of patients in the placebo group by week 48. No patients developed a serum creatinine increase >/= 0.5 mg/dL from baseline by week 48. By week 96, 10% and 2% of HEPSERA-treated patients, by Kaplan-Meier estimate, had increases in serum creatinine >/= 0.3 mg/dL and >/= 0.5 mg/dL from baseline, respectively (no placebo-controlled results were available for comparison beyond week 48). Of the 29 of 492 patients with elevations in serum creatinine >/= 0.3 mg/dL from baseline, 20 out of 29 resolved on continued treatment ((See Special Risk Patients section below for changes in serum creatinine in patients with underlying renal insufficiency at baseline).

  • Hepsera is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Hepsera 10 mg is not a controlled substance under the Controlled Substance Act (CSA).

    Hepsera is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Hepsera 10 mg is not a controlled substance under the Controlled Substance Act (CSA).

      HEPSERA 10 mg Placebo
    (n = 294) (n = 228)
    ALT (> 5 x ULN) 20% 41%
    Hematuria (>/= 3+) 11% 10%
    AST (> 5 x ULN) 8% 23%
    Creatine Kinase (> 4 x ULN) 7% 7%
    Amylase (> 2 x ULN) 4% 4%
    Glycosuria (>/= 3+) 1% 3%

  •   HEPSERA 10 mg Placebo
    (n = 294) (n = 228)
    Asthenia 13% 14%
    Headache 9% 10%
    Abdominal pain 9% 11%
    Nausea 5% 8%
    Flatulence 4% 4%
    Diarrhea 3% 4%
    Dyspepsia 3% 2%

    If you have complications with Hepsera 10mg after taking the product, and/or if you do not believe it is working properly, you must notify your doctor as soon as possible. Contact your doctor immediately if you think you are receiving an allergic reaction from Hepsera 10mg .

Buy Hepsera (Adefovir Dipivoxil) 10mg - Universal Drugstore

Hepsera is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Hepsera 10 mg is not a controlled substance under the Controlled Substance Act (CSA).